Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM)

Historical Holders from Q2 2024 to Q4 2025

Type / Class
Equity / Class A Common Stock, $0.001 par value per share
Symbol
CTNM on Nasdaq
Shares outstanding
21,500,623
Price per share
$10.49
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
17,478,081
Total reported value
$205,365,503
% of total 13F portfolios
0%
Share change
+3,621,729
Value change
+$48,626,432
Number of holders
61
Price from insider filings
$10.49
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $8,488,000 2,122,000 RA Capital Management, L.P. 18 Jul 2025
FRANKLIN RESOURCES INC 7.7% -13% $19,453,682 -$508,531 1,655,548 -2.5% Franklin Resources, Inc. 30 Sep 2025
SECTORAL ASSET MANAGEMENT INC 5% $4,297,553 950,786 Jerome G. Pfund 31 Dec 2024
PERCEPTIVE ADVISORS LLC 3.2% -54% $2,776,959 -$2,944,799 699,486 -51% Perceptive Advisors LLC 30 Jun 2025
As of 30 Sep 2025, Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) has 61 institutional shareholders filing 13F forms. They hold 17,478,081 shares. of 21,500,623 outstanding shares (81%) .

Top 25 institutional shareholders own 78% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
RA CAPITAL MANAGEMENT, L.P. 9.9% 2,122,000 0.31% $24,933,500
JOHNSON & JOHNSON 9.2% 1,979,173 0% 4.6% $23,255,283
SUVRETTA CAPITAL MANAGEMENT, LLC 8% 1,720,000 0% 0.61% $20,210,000
FRANKLIN RESOURCES INC 7.7% 1,655,548 -2.5% 0% $19,452,689
VANGUARD GROUP INC 4.5% 964,232 +30% 0% $11,329,726
Balyasny Asset Management L.P. 4.4% 951,320 0.02% $11,178,010
FMR LLC 3.8% 814,871 -3.4% 0% $9,574,734
SECTORAL ASSET MANAGEMENT INC 3.7% 800,787 0% 5.8% $9,409,247
PERCEPTIVE ADVISORS LLC 3.3% 714,592 +2.2% 0.25% $8,396,456
HHLR ADVISORS, LTD. 3.1% 669,337 0% 0.19% $7,864,710
MILLENNIUM MANAGEMENT LLC 3% 646,022 +388% 0.01% $7,590,758
RED TREE MANAGEMENT, LLC 3% 638,158 0% 9% $7,498,357
SAMSARA BIOCAPITAL, LLC 2.7% 571,142 -3% 0.88% $6,710,919
Versant Venture Management, LLC 2.5% 542,628 0% 3% $6,375,879
Point72 Asset Management, L.P. 1.7% 367,645 -5.4% 0.01% $4,319,828
BlackRock, Inc. 1.5% 322,031 +95% 0% $3,783,865
GEODE CAPITAL MANAGEMENT, LLC 0.98% 211,050 +196% 0% $2,481,056
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.95% 204,119 +914% 0% $2,398,398
MARSHALL WACE, LLP 0.9% 193,491 +575% 0% $2,273,522
SILVERARC CAPITAL MANAGEMENT, LLC 0.77% 166,161 0.28% $1,952,392
Casdin Capital, LLC 0.69% 148,333 0% 0.15% $1,742,913
Eversept Partners, LP 0.63% 134,619 0.12% $1,581,773
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.51% 110,178 +323% 0% $1,294,592
MORGAN STANLEY 0.43% 92,995 +0.1% 0% $1,092,692
ADAR1 Capital Management, LLC 0.36% 77,961 -53% 0.09% $916,042

Institutional Holders of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 0 $0 -$447 $10.49 0
2025 Q3 17,478,081 $205,365,503 +$48,626,432 $11.75 61
2025 Q2 13,856,430 $55,287,652 -$6,405,461 $3.97 68
2025 Q1 15,121,377 $105,552,026 -$10,223,173 $6.98 62
2024 Q4 15,761,089 $230,901,673 +$20,179,605 $14.65 60
2024 Q3 13,713,806 $258,404,333 +$11,041,962 $19.14 52
2024 Q2 13,016,510 $229,220,181 +$229,145,565 $17.61 49